Evidence map›Paper›PMID 42554957›Full record

ArticleDiscover nano2026

Evaluating antibacterial, antioxidant and apoptosis-mediated anticancer activities of green-synthesised silver nanoparticles using unicellular cyanobacterium Synechocystis pevaleikii.

Sagar Patra, Sanjana Sabat, Anusha Srivastava, Ajit Kumar Bishoyi, Rabindra Nath Padhy

Abstract read
In one paragraph

Article in Discover nano, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sagar PatraCentral Research Laboratory, Institute of Medical Sciences and SUM Hospital, Siksha 'O' Anusandhan Deemed University, Bhubaneswar, 751003, Odisha, India.ORCID http://orcid.org/0009-0009-0203-4910
Sanjana SabatCentral Research Laboratory, Institute of Medical Sciences and SUM Hospital, Siksha 'O' Anusandhan Deemed University, Bhubaneswar, 751003, Odisha, India.ORCID http://orcid.org/0009-0009-2243-7784
Anusha SrivastavaMehta Family School of Biosciences and Biomedical Engineering, Indian Institute of Technology Indore, Indore, Simrol, 453552, Madhya Pradesh, India.ORCID http://orcid.org/0000-0001-5092-9545
Ajit Kumar BishoyiCentral Research Laboratory, Institute of Medical Sciences and SUM Hospital, Siksha 'O' Anusandhan Deemed University, Bhubaneswar, 751003, Odisha, India. bishoyiajit96@gmail.com.ORCID http://orcid.org/0000-0002-7739-5616
Rabindra Nath PadhyCentral Research Laboratory, Institute of Medical Sciences and SUM Hospital, Siksha 'O' Anusandhan Deemed University, Bhubaneswar, 751003, Odisha, India. rnpadhy54@gmail.com.ORCID http://orcid.org/0000-0002-2522-9843

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The escalating threat of multidrug-resistant pathogens and aggressive malignancies demands sustainable alternatives to conventional therapeutics. Aligning with the One-Health approach, this study establishes an eco-friendly green nanotechnology platform utilising the unexploited marine unicellular cyanobacterium Synechocystis pevaleikii to biosynthesise stable, multifunctional silver nanoparticles (Sp-AgNPs). The synthesis using a 100 mg/10 mL aqueous biomass extract and 1 mM silver nitrate (AgNO

Indexed as

AntibacterialAntioxidantCancer cell cytotoxicityCyanobacteriumGreen nanotechnologySynechocystis pevaleikii

Identifiers

PMID42554957
PMCPMC13442771

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.